These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33230550)

  • 21. Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.
    Sáez-Llorens X; Clemens R; Leroux-Roels G; Jimeno J; Clemens SA; Weldon WC; Oberste MS; Molina N; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Mar; 16(3):321-30. PubMed ID: 26719058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India.
    Ahmad M; Verma H; Deshpande J; Kunwar A; Bavdekar A; Mahantashetti NS; Krishnamurthy B; Jain M; Mathew MA; Pawar SD; Sharma DK; Sethi R; Visalakshi J; Mohanty L; Bahl S; Haldar P; Sutter RW
    J Pediatric Infect Dis Soc; 2022 Feb; 11(2):60-68. PubMed ID: 34791350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants.
    Fadlyana E; Dhamayanti M; Tarigan R; Mulia Sari R; Sjafri Bachtiar N; Kartasasmita CB; Rusmil K
    Vaccine; 2020 Feb; 38(8):1962-1967. PubMed ID: 31982261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine.
    Zhao T; Li J; Shi H; Ye H; Ma R; Fu Y; Liu X; Li G; Yang X; Zhao Z; Yang J
    Hum Vaccin Immunother; 2021 Aug; 17(8):2560-2567. PubMed ID: 33848232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
    Lopez-Medina E; Melgar M; Gaensbauer JT; Bandyopadhyay AS; Borate BR; Weldon WC; Rüttimann R; Ward J; Clemens R; Asturias EJ
    Vaccine; 2017 Jun; 35(28):3591-3597. PubMed ID: 28455172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
    Gaensbauer JT; Gast C; Bandyopadhyay AS; O'Ryan M; Saez-Llorens X; Rivera L; Lopez-Medina E; Melgar M; Weldon WC; Oberste MS; Rüttimann R; Clemens R; Asturias EJ
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S57-S65. PubMed ID: 30376095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh.
    Aziz AB; Verma H; Jeyaseelan V; Yunus M; Nowrin S; Moore DD; Mainou BA; Mach O; Sutter RW; Zaman K
    J Infect Dis; 2022 Oct; 226(8):1319-1326. PubMed ID: 35575051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral and inactivated poliovirus vaccines in the newborn: a review.
    Mateen FJ; Shinohara RT; Sutter RW
    Vaccine; 2013 May; 31(21):2517-24. PubMed ID: 22728224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.
    Macklin GR; Grassly NC; Sutter RW; Mach O; Bandyopadhyay AS; Edmunds WJ; O'Reilly KM
    Lancet Infect Dis; 2019 Oct; 19(10):1121-1128. PubMed ID: 31350192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.
    Mir F; Quadri F; Mach O; Ahmed I; Bhatti Z; Khan A; Rehman NU; Durry E; Salama M; Oberste SM; Weldon WC; Sutter RW; Zaidi AK
    Lancet Infect Dis; 2015 Aug; 15(8):889-97. PubMed ID: 26093979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.
    John J; Giri S; Karthikeyan AS; Lata D; Jeyapaul S; Rajan AK; Kumar N; Dhanapal P; Venkatesan J; Mani M; Hanusha J; Raman U; Moses PD; Abraham A; Bahl S; Bandyopadhyay AS; Ahmad M; Grassly NC; Kang G
    J Infect Dis; 2017 Feb; 215(4):529-536. PubMed ID: 28003352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
    Wilkinson AL; Zaman K; Hoque M; Estivariz CF; Burns CC; Konopka-Anstadt JL; Mainou BA; Kovacs SD; An Q; Lickness JS; Yunus M; Snider CJ; Zhang Y; Coffee E; Abid T; Wassilak SGF; Pallansch MA; Oberste MS; Vertefeuille JF; Anand A
    Lancet Infect Dis; 2023 Sep; 23(9):1062-1071. PubMed ID: 37178706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine.
    Xu J; Liu Y; Qiu W; Li W; Hu X; Li X; Fan Q; Tang W; Wang Y; Wang Q; Yao N
    BMC Infect Dis; 2024 May; 24(1):535. PubMed ID: 38807038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
    Cuba IPV Study Collaborative Group
    N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.
    Snider CJ; Zaman K; Wilkinson AL; Binte Aziz A; Yunus M; Haque W; Jones KAV; Wei L; Estivariz CF; Konopka-Anstadt JL; Mainou BA; Patel JC; Lickness JS; Pallansch MA; Wassilak SGF; Steven Oberste M; Anand A
    Vaccine; 2023 Sep; 41(41):6083-6092. PubMed ID: 37652822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.
    Sutter RW; John TJ; Jain H; Agarkhedkar S; Ramanan PV; Verma H; Deshpande J; Singh AP; Sreevatsava M; Malankar P; Burton A; Chatterjee A; Jafari H; Aylward RB
    Lancet; 2010 Nov; 376(9753):1682-8. PubMed ID: 20980048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
    Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013.
    Habib MA; Soofi S; Mach O; Samejo T; Alam D; Bhatti Z; Weldon WC; Oberste SM; Sutter R; Bhutta ZA
    Vaccine; 2016 Jul; 34(33):3803-9. PubMed ID: 27269054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.
    Rivera L; Pedersen RS; Peña L; Olsen KJ; Andreasen LV; Kromann I; Nielsen PI; Sørensen C; Dietrich J; Bandyopadhyay AS; Thierry-Carstensen B
    Lancet Infect Dis; 2017 Jul; 17(7):745-753. PubMed ID: 28454674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.